Hepatitis Monthly

Published by: Kowsar

Serolological Profile Among HBsAg-Positive Infections in Southeast China: A Community-Based Study

Ping Chen 1 , Chengbo Yu 1 , Wei Wu 1 , Jinghua Wang 1 , Bing Ruan 1 , Jingjing Ren 1 , Shigui Yang 1 , Kaijin Xu 1 , Liang Yu 1 and Lanjuan Li 1 , *
Authors Information
1 State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Article information
  • Hepatitis Monthly: January 01, 2013, 13 (1); e7604
  • Published Online: January 23, 2013
  • Article Type: Research Article
  • Received: August 11, 2012
  • Revised: November 27, 2012
  • Accepted: December 24, 2012
  • DOI: 10.5812/hepatmon.7604

To Cite: Chen P, Yu C, Wu W, Wang J, Ruan B, et al. Serolological Profile Among HBsAg-Positive Infections in Southeast China: A Community-Based Study, Hepat Mon. 2013 ; 13(1):e7604. doi: 10.5812/hepatmon.7604.

Copyright © 2013, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Han YF, Zhao J, Ma LY, Yin JH, Chang WJ, Zhang HW, et al. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma. World J Gastroenterol. 2011; 17(38): 4258-70[DOI][PubMed]
  • 2. Tan YJ. Hepatitis B virus infection and the risk of hepatocellular carcinoma. World J Gastroenterol. 2011; 17(44): 4853-7[DOI][PubMed]
  • 3. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009; 27(47): 6550-7[DOI][PubMed]
  • 4. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009; 373(9663): 582-92[DOI][PubMed]
  • 5. Liaw YF. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment. Liver Int. 2009; 29 Suppl 1: 100-7[DOI][PubMed]
  • 6. Li T, Du H, Zhang HY. HBV genotype and its association to chronic HBV infection in Beijing. China. J Gastroenterol Hepatol. 2004; 19
  • 7. Luo Z, Xie Y, Deng M, Zhou X, Ruan B. Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size. Eur J Gastroenterol Hepatol. 2011; 23(8): 695-700[DOI][PubMed]
  • 8. Xia GL, Liu CB, Cao HL, Bi SL, Zhan MY, Su CA, et al. Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992. Int Hepatol Commun. 1996; 5(1): 62-73[DOI]
  • 9. Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology. 2002; 35(6): 1522-7[DOI][PubMed]
  • 10. Liaw YF. Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy. J Gastroenterol Hepatol. 2003; 18(3): 246-52[PubMed]
  • 11. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med. 2002; 347(3): 168-74[DOI][PubMed]
  • 12. Chan HL, Leung NW, Hussain M, Wong ML, Lok AS. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong. Hepatology. 2000; 31(3): 763-8[DOI][PubMed]
  • 13. Lok AS, Lai CL, Wu PC, Leung EK, Lam TS. Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology. 1987; 92(6): 1839-43[PubMed]
  • 14. Carman WF, Hadziyannis S, McGarvey MJ, Jacyna MR, Karayiannis P, Makris A, et al. MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION. Lancet. 1989; 334(8663): 588-91[DOI]
  • 15. Stroffolini T, Almasio PL, Sagnelli E, Mele A, Gaeta GB. Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study. J Med Virol. 2009; 81(12): 1999-2006[DOI][PubMed]
  • 16. Zarski JP. Épidémiologie de l’hépatite chronique B. La Presse Médicale. 2006; 35(2, Part 2): 304-7[DOI]
  • 17. McMahon BJ, Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med. 2001; 135(9): 759-68[PubMed]
  • 18. Abebe A, Nokes DJ, Dejene A, Enquselassie F, Messele T, Cutts FT. Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control. Epidemiol Infect. 2003; 131(1): 757-70[PubMed]
  • 19. Tsai NC, Holck PS, Wong LL, Ricalde AA. Seroepidemiology of hepatitis B virus infection: analysis of mass screening in Hawaii. Hepatol Int. 2008; 2(4): 478-85[DOI][PubMed]
  • 20. Jardi R, Buti M, Rodriguez-Frias F, Cortina M, Esteban R, Guardia J, et al. The value of quantiative detection of HBV-DNA amplified by PCR in the study of hepatitis B infection. J Hepatol. 1996; 24(6): 680-5
  • 21. Hasan KN, Rumi MA, Hasanat MA, Azam MG, Ahmed S, Salam MA, et al. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests. Southeast Asian J Trop Med Public Health. 2002; 33(1): 110-7[PubMed]
  • 22. Rabbi FJ, Rezwan MK, Shirin T. HBeAg/anti-HBe, alanine aminotransferase and HBV DNA levels in HBsAg positive chronic carriers. Bangladesh Med Res Counc Bull. 2008; 34(2): 39-43[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments